{
  "trial_id": "NCT03238235",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Ambulant patients with BMD diagnosis confirmed by genetic testing.",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Able and willing to give informed consent in writing.",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Able to perform 6MWT at screening with a minimum distance of 200 m and maximum distance of 450 m.",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Exposure to another investigational drug within 3 months prior to the start of study treatment.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Use of any pharmacologic treatment, other than corticosteroids, that might have an effect on muscle strength or function within 3 months prior to the start of study treatment (e.g., growth hormone). Vitamin D, calcium, and any other supplements will be allowed.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Surgery that might affect muscle strength or function within 3 months before study entry or planned surgery at any time during the study.",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "The patient has a known history of sickle cell disease and has had positive history of sickle cell crises since childhood. He also had severe pain in his lower back that radiated to both thighs scored 9 out of 10.",
  "_meta": {
    "topic_id": "45",
    "trial_id": "NCT03238235",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}